X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/03/28/2853960/0/en/Ocean-Biomedical-NASDAQ-OCEA-Congratulates-JV-Partner-Virion-Therapeutics-on-Promising-First-Ever-Human-Phase-1B-Clinical-Safety-Data-for-Their-Lead-Checkpoint-Modifier-Containing-.html
https://www.prnewswire.com/news-releases/promising-first-in-human-phase-1b-clinical-study-data-from-vron-0200-a-novel-first-in-class-checkpoint-modifier-immunotherapy-for-chronic-hepatitis-b-virus-functional-cure-presented-as-late-breaker-at-2024-apasl-global-liver-me-302100640.html
https://www.globenewswire.com//news-release/2024/02/29/2837935/0/en/Ocean-Biomedical-NASDAQ-OCEA-Announces-Joint-Venture-Partner-Virion-Therapeutics-to-Present-Their-First-Clinical-Study-Data-as-an-Accepted-Late-Breaker-Presentation-at-2024-APASL-G.html
https://www.globenewswire.com//news-release/2023/10/26/2767238/0/en/Ocean-Biomedical-NASDAQ-OCEA-Announces-First-Patients-Dosed-by-Joint-Venture-Partner-Virion-Therapeutics-in-Phase-1b-Study-of-Novel-Immunotherapy-for-Chronic-Hepatitis-B-Virus-Infe.html
https://www.globenewswire.com//news-release/2023/10/12/2759202/0/en/Ocean-Biomedical-and-Virion-Therapeutics-Form-Joint-Venture-Supporting-Multi-National-First-In-Humans-Clinical-Chronic-Hepatitis-B-Study-Now-Enrolling-With-Goal-of-a-Functional-Cur.html
https://www.prnewswire.com/news-releases/virion-therapeutics-presents-vron-0200-preclinical-data-showing-direct-correlations-between-intrahepatic-cd8-t-cells-and-hepatitis-b-virus-declines-hbv-at-easl-2023-301853144.html
https://www.prnewswire.com/news-releases/virion-therapeutics-presents-promising-preclinical-cancer-data-when-using-a-novel-genetically-encoded-checkpoint-modifier-based-immunotherapy-301762092.html
https://www.contractpharma.com/contents/view_breaking-news/2023-02-22/cbm-virion-partner-on-cd8t-cell-based-clinical-development-programs/?widget=listSection
https://www.prnewswire.com/news-releases/center-for-breakthrough-medicines-and-virion-therapeutics-announce-strategic-partnership-to-manufacture-virions-proprietary-cd8-t-cell-based-clinical-development-programs-for-infectious-diseases-and-cancers-301752606.html
Market Place
Share 
